This approach encourages macrophages to phagocytose irradiated tumor cells, enhances antigen cross-presentation, and ultimately boosts the infiltration and activity of CD8+ and CD4+ T-cells (Boone et al., 2022). The gene discussed is CD4; the disease is neoplasm.